Can Angiogenesis be a Target of Treatment for Ribavirin Associated Hemolytic Anemia?
HEPATO-GASTROENTEROLOGY, cilt.57, ss.562-566, 2010 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 57
- Basım Tarihi: 2010
- Dergi Adı: HEPATO-GASTROENTEROLOGY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.562-566
- Hacettepe Üniversitesi Adresli: Evet
Özet
Background/Aims: Recently ribavirin has been found to inhibit angiogenesis and a number of angiogenesis inhibitors such as sunitinib and sorafenib have been found to cause acute hemolysis. We aimed to investigate whether there is a relation between hemoglobin, haptoglobin and angiogenesis soluble markers which are modifiable and can help in developing strategies against anemia.